|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study)显示文摘AIM: To establish which scolicidal agents are superiorand more suitable for regular use.METHODS: Echinococcus granulosus protoscoleceswere obtained from 25 patients with liver hydatidcysts. Various concentrations of albendazole sulfone,albendazole sulfoxide, and albendazole sulfone andalbendazole sulfoxide mixed together in concentrationsof 50 μg/mL, and H2O2 in a concentration of 4%, NaCl20%, and 1.5% cetrimide-0.15% chlorhexidine (10%Savlon-Turkey) were used to determine the scolicidaleffects. Albendazole (ABZ) derivatives and otherscolicidal agents were applied to a minimum of 100scoleces for 5 and 10 min. The degree of viability wascalculated according to the number of living scolicesper fi eld from a total of 100 scolices observed underthe microscope.RESULTS: After 5 min, ABZ sulfone was 97.3%effective, ABZ sulfoxide was 98.4% effective, and thecombined solution was 98.6% effective. When sulfone,sulfoxide and the combined solutions were compared,the combined solution seemed more effective thansulfone. However, there was no difference when thecombined solution was compared with sulfoxide. After10 min, hypertonic salt water, sulfone, sulfoxide, andthe combined solution compared to other solutionslooked more effective and this was statisticallysignificant on an advanced level. When sulfone,sulfoxide, and the combined solutions were compared with each other, the combined solution appeared more effective than sulfone. When the combined solution was compared with sulfoxide, there was no difference.CONCLUSION: Despite being active, ABZ metabolites did not provide a marked advantage over 20% hypertonic saline. According to these results, we think creating a newly improved and more active preparation is necessary for hydatid cyst treatment. | Gokhan Adas Soykan Arikan Ozgur Kemik Ali Oner Nilgun Sahip Oguzhan Karatepe | 2009 | World Journal of Gastroenterology2009，15，1： | 19 |
| 2 | Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide显示文摘AIM: To evaluate prospectively immediate intraocular pressure (IOP) changes after the intravitreal injection of ranibizumab, 2 and 4mg triamcinolone acetonide. METHODS: Patients who underwent intravitreal injection of 0.1mL (4mg) triamcinolone acetonide (TA, Group T4), 0.05mL (2mg) TA (Group T2) and 0.05mL (0.5mg) ranibizumab (Group R) comprised the study population. Overall, 229 eyes of 205 patients were injected. Fifty-four eyes (23.6%) were in Group T4, 69 eyes (30.1%) in Group T2 and 106 eyes (46.3%) in Group R. If IOP was less than 26mmHg immediately after the injection no further measurement was performed. If IOP was ≥26mmHg, IOP was remeasured till the reading was below 26mmHg at 5, 15 and 30 minutes. RESULTS: Immediately after the injection, the IOP of 28 eyes (51.9%) in Group T4, 22 eyes (31.9%) in Group T2 and 51 eyes (48.1%) in Group R were over 25mmHg. At 30 minutes, IOP of one eye (1.9%) in group T4, two eyes (2.9%) in group T2 and two eyes (1.9 %) in Group R were over 25mmHg. Immediate post-injection IOP was significantly higher in Group T4 and Group R when compared to Group T2 (P <0.001 and P <0.001, respectively). IOP was significantly higher in eyes without vitreous reflux when compared to those with vitreous reflux in all groups (P <0.001). CONCLUSION: IOP may remarkably increase immediately after the intravitreal injection of 2 or 4mg triamcinolone acetonide, and 0.5mg ranibizumab. Absence of vitreous reflux is the most important predicting factor for immediate IOP rise after the injection. | Gul Arikan Ali Osman Saatci Ferit Hakan Oner | 2011 | International Journal of Ophthalmology(English edition)2011，4，4： | 6 |
| 3 | Color Doppler Imaging of Ocular Hemodynamic Changes in Beh?et Disease and Uveitis Patients with Different Etiologies显示文摘 | Ayse Oner Ali Akal Nuri Erdogan Hakki Dogan Mithat Oner | 2006 | Current Eye Research2006，，6： | 1 |
| 4 | 兰尼单抗和曲安奈德玻璃体内注射后眼压的即时升高(英文)显示文摘目的:前瞻性评估玻璃体腔内注射兰尼单抗、2和4mg曲安奈德(TA)后眼压(IOP)的即时变化。方法:接受玻璃体腔内注射0.1mL(4mg)曲安奈德(T4组),0.05mL(2mg)TA(T2组)和0.05mL(0.5mg)兰尼单抗(R组)的患者组成研究群体。总体而言,205例229眼接受注射。T4组54眼(23.6%),T2组69眼(30.1%),及R组106眼(46.3%)。如果注射后即时眼压<26mmHg就不行进一步的测量。如果眼压≥26mmHg,就在5,15和30min后重新测量眼压,直到读数<26mmHg。结果:注射后即时眼压,T4组28眼(51.9%),T2组22眼(31.9%)和R组51眼(48.1%)超过25mmHg。到30min时,T4组1眼(1.9%),T2组2眼(2.9%)和R组2眼(1.9%),眼压超过25mmHg。T4组和R组注射后即时眼压显著高于T2组(P<0.01和P<0.01)。各组中无玻璃体回流眼的眼压显著高于有玻璃体回流眼(P<0.01)。结论:玻璃体腔内注射2或4mg曲安奈德和0.5mg的兰尼单抗后眼压可能会立即显著提高。无玻璃体回流是注射后眼压即时上升的最重要的预测因素。 | Gul Arikan Ali Osman Saatci Ferit Hakan Oner | 2011 | 国际眼科杂志2011，11，9： | 1 |
| 5 | Our Long‐Term Results of Tenckhoff Peritoneal Dialysis Catheters Placement via Laparoscopic Preperitoneal Tunneling Technique显示文摘 | Fatma A. Gultekin Guldeniz K. Cakmak Kemal Karakaya Ali U. Emre Oge Tascilar Muzaffer O. Oner Mustafa Comert Eyup Kulah | 2012 | Seminars in Dialysis2012，，3： | 1 |
| 6 | The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method显示文摘 | Sena Izmirli Deniz Gozde Celik Pelin Yuksel Suat Saribas Mustafa Aslan Sevgi Ergin Hrisi Bahar Sümeyye Sen Bulent Cakal Ali Oner Bekir Kocazeybek | 2012 | Transfusion and Apheresis Science2012，，3： | 1 |
| 7 | Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration显示文摘AIM:To compare the efficacy of low-fluence photodynamic therapy(PDT) combinations in the treatment of age-related macular degeneration(AMD).· METHODS:Forty-five previously untreated eyes of 45 patients with exudative AMD whose best-corrected visual acuity(BCVA) was ≥0.3(Snellen) were enrolled.15 patients in Group I underwent low-fluence PDT(25J/cm2-300mW/cm2-83sec) and intravitreal pegaptanib combination,15 patients in Group II underwent PDT(50J/cm2-600mW/cm2-83sec) and intravitreal pegaptanib combination while,15 patients in Group III underwent intravitreal pegaptanib monotherapy.Complete ophthalmologic examinations were performed in pre and post treatment visits,and the results were statistically analised.A clinical activity score(CAS) was calculated by using changes in lesion size,amount of hemorrhage,staining pattern in FA and OCT measurement of intra/subretinal fluid.≤3 logMAR lines of decrease in BCVA and decrease in CAS were considered as successful treatment.· RESULTS:The mean age of 19 female(42.2%) and 26 male(57.8%) patients was(72.82±8.02) years.Mean follow-up was(13.93±5.87) months.Lesion type was occult in 28 eyes(62.2%).Treatment success rates according to BCVA assessments were 86.7%,80%,60% and mean BCVA decrease were 0.3,1.0,2.2 logMAR lines in Group I,II and III,respectively(P >0.05).According to the changes in central macular thickness and CAS,no difference was found among the study groups(P =0.850 and P =0.811,respectively).Patients treated with combination regimens had lower intravitreal injection frequencies(P =0.015).· CONCLUSION:Combination regimen with intravitreal pegaptanib and low-fluence PDT seems to be safe and effective in stabilizing the clinical activity and BCVA in exudative AMD. | Taylan Ozturk Hakan Oner Ali Osman Saatci Suleyman Kaynak | 2012 | International Journal of Ophthalmology(English edition)2012，5，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员